A glimmer of hope in treating Alzheimer’s illness

Neuroscientists are celebrating this week’s publication of the firmest proof thus far of a therapy that slows the horrible, inexorable descent into dementia brought on by Alzheimer’s illness. Lecanemab, developed collectively by…

Goldman Sachs bonus pool shrinks

David Solomon, chief government officer of Goldman Sachs, speaks throughout the Milken Institute International Convention in Beverly Hills, April 29, 2019.Patrick T. Fallon | Bloomberg | Getty PhotographsGoldman Sachs merchants and…